These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9755663)
1. Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants. Cheng L; Wolf NG; Rose PG; Rodriguez M; Abdul-Karim FW Acta Cytol; 1998; 42(5):1091-4. PubMed ID: 9755663 [TBL] [Abstract][Full Text] [Related]
2. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Mulvany N Acta Cytol; 1996; 40(6):1231-9. PubMed ID: 8960034 [TBL] [Abstract][Full Text] [Related]
3. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome. Sneige N; Thomison JB; Malpica A; Gong Y; Ensor J; Silva EG Cancer Cytopathol; 2012 Aug; 120(4):238-44. PubMed ID: 22826172 [TBL] [Abstract][Full Text] [Related]
4. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings. Fadare O; Mariappan MR; Wang S; Hileeto D; McAlpine J; Rimm DL Cancer; 2004 Jun; 102(3):150-6. PubMed ID: 15211473 [TBL] [Abstract][Full Text] [Related]
5. Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters. Naz S; Hashmi AA; Ali R; Faridi N; Hussian SD; Edhi MM; Khan M World J Surg Oncol; 2015 Nov; 13():315. PubMed ID: 26556439 [TBL] [Abstract][Full Text] [Related]
6. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis. Davidson W; Madan R; O'Neil M; Tawfik OW; Fan F Ann Diagn Pathol; 2016 Jun; 22():54-7. PubMed ID: 27180061 [TBL] [Abstract][Full Text] [Related]
7. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. Zuna RE; Behrens A J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429 [TBL] [Abstract][Full Text] [Related]
8. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions. Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488 [TBL] [Abstract][Full Text] [Related]
9. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer. Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133 [TBL] [Abstract][Full Text] [Related]
10. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Kennedy AW; Hart WR Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004 [TBL] [Abstract][Full Text] [Related]
11. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related]
12. Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal "implants". Segal GH; Hart WR Am J Surg Pathol; 1992 Jun; 16(6):577-83. PubMed ID: 1599036 [TBL] [Abstract][Full Text] [Related]
14. Current concepts in management of epithelial ovarian tumors of low malignant potential. Elchalal U; Dgani R; Piura B; Anteby SO; Zalel Y; Czernobilsky B; Schenker JG Obstet Gynecol Surv; 1995 Jan; 50(1):62-70. PubMed ID: 7891967 [TBL] [Abstract][Full Text] [Related]
15. Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients. Kudo R; Takashina T; Ito E; Mizuuchi H; Sagae S; Moriwaka O; Tamagawa A Acta Cytol; 1990; 34(4):545-8. PubMed ID: 2375223 [TBL] [Abstract][Full Text] [Related]
16. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. McKenney JK; Balzer BL; Longacre TA Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150 [TBL] [Abstract][Full Text] [Related]
17. [The value of peritoneal cytology in the staging of ovarian cancer]. Emerich J; Konefka T; Dudziak M; Sobol A Ginekol Pol; 1997 Feb; 68(2):74-7. PubMed ID: 9499000 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Parameters Associated With Peritoneal Involvement in Epithelial Ovarian Tumors. Hashmi AA; Rashid K; Asif MG; Dowlah TU; Ali AH; Malik UA; Ali SM; Ali SJ; Zia S; Irfan M Cureus; 2023 Mar; 15(3):e36666. PubMed ID: 37102035 [TBL] [Abstract][Full Text] [Related]
19. Peritoneal washing cytology in cervical carcinoma. Analysis of 109 patients. Zuna RE; Hansen K; Mann W Acta Cytol; 1990; 34(5):645-51. PubMed ID: 2220243 [TBL] [Abstract][Full Text] [Related]
20. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Rubin SC; Dulaney ED; Markman M; Hoskins WJ; Saigo PE; Lewis JL Obstet Gynecol; 1988 Jun; 71(6 Pt 1):851-3. PubMed ID: 3285264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]